Teva names two new executives

JERUSALEM — Teva Pharmaceutical Industries has named Carlo De Notaristefani as president and CEO of global operations and Aharon "Arik" Yaari as EVP community and institutional affairs, the Israeli drug maker said Thursday.



The company said De Notaristefani and Yaari would report directly to Teva president and CEO Jeremy Levin.



"We are delighted to have Carlo and Arik in these roles," Levin said. "Teva has a long history of bringing affordable medicines to patients around the world. Through its founding days in Israel, the company has prided itself on the people who have contributed to making Teva a leader in both generic and branded medicines."

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.